Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review
about
Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth.PD-1 as a potential target in cancer therapy.Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system.
P2860
Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@ast
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@en
type
label
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@ast
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@en
prefLabel
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@ast
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@en
P2093
P2860
P356
P1476
Interferon-alfa in the treatme ...... carcinoma: a systematic review
@en
P2093
Christina Canil
Eric Winquist
Linda A Mayhew
Sebastien Hotte
Tricia S Waldron
P2860
P304
P356
10.5489/CUAJ.853
P577
2010-06-01T00:00:00Z